Two Sigma Advisers LP Invests $625,000 in Tempus AI, Inc. (NASDAQ:TEM)

Two Sigma Advisers LP purchased a new stake in shares of Tempus AI, Inc. (NASDAQ:TEM - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 18,500 shares of the company's stock, valued at approximately $625,000.

Several other hedge funds and other institutional investors also recently modified their holdings of TEM. Operose Advisors LLC acquired a new position in shares of Tempus AI during the fourth quarter valued at $25,000. Farther Finance Advisors LLC bought a new stake in Tempus AI in the fourth quarter worth about $34,000. Prestige Wealth Management Group LLC raised its position in Tempus AI by 910.4% in the fourth quarter. Prestige Wealth Management Group LLC now owns 1,071 shares of the company's stock worth $36,000 after acquiring an additional 965 shares in the last quarter. NewEdge Advisors LLC acquired a new stake in Tempus AI during the 4th quarter worth about $49,000. Finally, First Horizon Advisors Inc. raised its holdings in Tempus AI by 207.9% during the 4th quarter. First Horizon Advisors Inc. now owns 1,641 shares of the company's stock worth $55,000 after buying an additional 1,108 shares during the period. Institutional investors and hedge funds own 24.22% of the company's stock.

Wall Street Analysts Forecast Growth

TEM has been the topic of several research analyst reports. Wolfe Research cut Tempus AI from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, February 26th. JPMorgan Chase & Co. cut Tempus AI from an "overweight" rating to a "neutral" rating and lifted their target price for the company from $50.00 to $55.00 in a research note on Tuesday, February 25th. Morgan Stanley lifted their target price on Tempus AI from $60.00 to $65.00 and gave the company an "overweight" rating in a research note on Friday, May 9th. Needham & Company LLC reaffirmed a "buy" rating and set a $70.00 target price on shares of Tempus AI in a research note on Wednesday, May 7th. Finally, William Blair reaffirmed a "market perform" rating on shares of Tempus AI in a research note on Tuesday, February 25th. Six analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $63.42.

Tempus AI Stock Down 6.6%

Shares of NASDAQ TEM traded down $4.12 during trading hours on Thursday, hitting $58.66. The stock had a trading volume of 12,213,960 shares, compared to its average volume of 6,836,493. The company has a market capitalization of $10.15 billion and a P/E ratio of -7.52. The firm's 50-day moving average price is $52.78 and its two-hundred day moving average price is $51.98. Tempus AI, Inc. has a 52 week low of $22.89 and a 52 week high of $91.45. The company has a debt-to-equity ratio of 8.17, a quick ratio of 2.55 and a current ratio of 2.69.

Tempus AI (NASDAQ:TEM - Get Free Report) last announced its quarterly earnings results on Tuesday, May 6th. The company reported ($0.24) EPS for the quarter, beating the consensus estimate of ($0.27) by $0.03. The firm had revenue of $255.74 million during the quarter, compared to the consensus estimate of $248.13 million. Tempus AI's revenue for the quarter was up 75.4% on a year-over-year basis. Analysts anticipate that Tempus AI, Inc. will post -6.15 EPS for the current fiscal year.

Insiders Place Their Bets

In other Tempus AI news, EVP Andrew Polovin sold 17,552 shares of the company's stock in a transaction that occurred on Tuesday, May 20th. The stock was sold at an average price of $63.43, for a total transaction of $1,113,323.36. Following the completion of the sale, the executive vice president now owns 138,877 shares of the company's stock, valued at $8,808,968.11. This represents a 11.22% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO James William Rogers sold 23,030 shares of the company's stock in a transaction that occurred on Tuesday, March 18th. The stock was sold at an average price of $45.97, for a total value of $1,058,689.10. Following the sale, the chief financial officer now directly owns 164,750 shares of the company's stock, valued at $7,573,557.50. The trade was a 12.26% decrease in their position. The disclosure for this sale can be found here. Insiders sold 139,888 shares of company stock valued at $7,938,111 over the last 90 days. 27.60% of the stock is currently owned by company insiders.

Tempus AI Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.